OMER vs ZYME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

OMER

54.2
AI Score
VS
ZYME Wins

ZYME

60.3
AI Score

Investment Advisor Scores

OMER

54score
Recommendation
HOLD

ZYME

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric OMER ZYME Winner
Forward P/E 87.7193 20.8333 ZYME
PEG Ratio 0.8053 0 Tie
Revenue Growth 14.9% -90.6% OMER
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 54.2/100 60.3/100 ZYME
Profit Margin 324.9% 0.0% OMER
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

OMER 1M: -1.3% · 3M: +80.0% ZYME 1M: -19.0% · 3M: -0.7%

Current Technical Phase

OMER

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (27.0% over 20 days), RSI 51

RSI (14): 51.2 · Price: $18.61

ZYME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.2 · Price: $25.15

Fundamentals Snapshot

Metric OMER ZYME
Market Cap — —
Forward P/E 15.1 28.9
Trailing P/E 11.2 —
Revenue (TTM) — —
Revenue Growth 0.1% -0.9%
Gross Margin 0.4% -2.5%
Operating Margin 0.0% -9.2%
EPS 1.65 -2.02
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZYME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.